Cargando…

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial

BACKGROUND: Young women in sub-Saharan Africa bear a disproportionate burden of HIV infection compared to men but have limited options to reduce their HIV risk. Microbicides could fill an important HIV prevention gap for sexually active women who are unable to successfully negotiate mutual monogamy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karim, Quarraisha Abdool, Kharsany, Ayesha BM, Frohlich, Janet A, Baxter, Cheryl, Yende, Nonhlanhla, Mansoor, Leila E, Mlisana, Koleka P, Maarschalk, Silvia, Arulappan, Natasha, Grobler, Anneke, Sibeko, Sengeziwe, Omar, Zaheen, Gengiah, Tanuja N, Mlotshwa, Mukelisiwe, Samsunder, Natasha, Abdool Karim, Salim S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063209/ https://www.ncbi.nlm.nih.gov/pubmed/21385354 http://dx.doi.org/10.1186/1745-6215-12-67

Ejemplares similares

Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial
por: Matthews, Lynn T., et al.
Publicado: (2013)

HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services
por: Kharsany, Ayesha BM, et al.
Publicado: (2012)

Age-Restriction of a Validated Risk Scoring Tool Better Predicts HIV Acquisition in South African Women: CAPRISA 004
por: Castor, Delivette, et al.
Publicado: (2022)

Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
por: Burgers, WA, et al.
Publicado: (2012)

CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women
por: Gengiah, Tanuja Narayansamy, et al.
Publicado: (2022)

Establishing a Cohort at High Risk of HIV Infection in South Africa: Challenges and Experiences of the CAPRISA 002 Acute Infection Study
por: van Loggerenberg, Francois, et al.
Publicado: (2008)

Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial
por: Succop, Stacey M., et al.
Publicado: (2014)

Assessing Adherence in the CAPRISA 004 Tenofovir Gel HIV Prevention Trial: Results of a Nested Case–Control Study
por: MacQueen, Kathleen M., et al.
Publicado: (2014)

Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women
por: Joag, Vineet, et al.
Publicado: (2018)

Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial
por: Mahomed, Sharana, et al.
Publicado: (2019)

High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa
por: Msomi, Nokukhanya, et al.
Publicado: (2020)

No Evidence for Selection of HIV-1 with Enhanced Gag-Protease or Nef Function among Breakthrough Infections in the CAPRISA 004 Tenofovir Microbicide Trial
por: Chopera, Denis R., et al.
Publicado: (2013)

HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition
por: Liebenberg, Lenine J. P., et al.
Publicado: (2019)

Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial
por: Mahomed, Sharana, et al.
Publicado: (2023)

Enrolling Adolescents in Research on HIV and Other Sensitive Issues: Lessons from South Africa
por: Singh, Jerome Amir, et al.
Publicado: (2006)

Integrated provision of topical pre‐exposure prophylaxis in routine family planning services in South Africa: a non‐inferiority randomized controlled trial
por: Mansoor, Leila E, et al.
Publicado: (2019)

Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial
por: Mahomed, Sharana, et al.
Publicado: (2020)

Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa
por: Kharsany, Ayesha B. M., et al.
Publicado: (2019)

Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression
por: Ngcobo, Samukelisiwe, et al.
Publicado: (2022)

Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa
por: Pillay, Kimesha, et al.
Publicado: (2021)

Current status of the HIV epidemic & challenges in prevention
por: Karim, Quarraisha Abdool
Publicado: (2017)

Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial
por: Mansoor, Leila E, et al.
Publicado: (2014)

Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South Africa
por: Mansoor, Leila E., et al.
Publicado: (2022)

Anaemia in Acute HIV-1 Subtype C Infection
por: Mlisana, Koleka, et al.
Publicado: (2008)

Epigenetic Regulation of BST-2 Expression Levels and the Effect on HIV-1 Pathogenesis
por: Singh, Ravesh, et al.
Publicado: (2021)

Mortality in HIV and tuberculosis patients following implementation of integrated HIV-TB treatment: Results from an open-label cluster-randomized trial
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol
por: Naidoo, Kogieleum, et al.
Publicado: (2017)

Correction to: Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol
por: Naidoo, Kogieleum, et al.
Publicado: (2019)

Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa
por: Naicker, Nivashnee, et al.
Publicado: (2022)

Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision
por: Humphries, Hilton, et al.
Publicado: (2022)

Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women
por: Naranbhai, V., et al.
Publicado: (2016)

Inclusion of adolescent girls in HIV prevention research – an imperative for an AIDS-free generation
por: Karim, Quarraisha Abdool, et al.
Publicado: (2014)

COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa
por: Abdool Karim, Quarraisha, et al.
Publicado: (2022)

Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa
por: Kharsany, Ayesha BM, et al.
Publicado: (2015)

Clinical Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Rapid Antigen Tests During the Omicron Wave in South Africa( )
por: Samsunder, Natasha, et al.
Publicado: (2022)

HIV-Associated Tuberculosis
por: Naidoo, Kogieleum, et al.
Publicado: (2011)

Mechanisms of sexually transmitted infection‐induced inflammation in women: implications for HIV risk
por: Mwatelah, Ruth, et al.
Publicado: (2019)

Field evaluations of four SARS-CoV-2 rapid antigen tests during SARS-CoV-2 Delta variant wave in South Africa
por: Samsunder, Natasha, et al.
Publicado: (2023)

Putting women in the centre of the global HIV response is key to achieving epidemic control!
por: Abdool Karim, Quarraisha, et al.
Publicado: (2020)

ARV-based HIV prevention for women – where we are in 2014
por: Mastro, Timothy D, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mvemccosn6rpcb9tlb4uukv6cb